Compact magneto-optical trap of thulium atoms for a transportable optical clock.

We have developed a compact vacuum system for laser cooling and spectroscopy of neutral thulium atoms. Compactness is achieved by obviating a classical Zeeman slower section and placing an atomic oven close to a magneto-optical trap (MOT), specifically at the distance of 11 cm. In this configuration, we significantly gained in solid angle of an atomic beam, which is affected by MOT laser beams, and reached 1 million atoms loaded directly in the MOT with only 15 mW of MOT cooling beams net power.

Simultaneous bicolor interrogation in thulium optical clock providing very low systematic frequency shifts.

Optical atomic clocks have already overcome the eighteenth decimal digit of instability and uncertainty, demonstrating incredible control over external perturbations of the clock transition frequency. At the same time, there is an increasing demand for atomic (ionic) transitions and new interrogation and readout protocols providing minimal sensitivity to external fields and possessing practical operational wavelengths. One of the goals is to simplify the clock operation while maintaining the relative uncertainty at a low 10 level achieved at the shortest averaging time.

Preclinical Studies of Immunogenity, Protectivity, and Safety of the Combined Vector Vaccine for Prevention of the Middle East Respiratory Syndrome.

The Middle East Respiratory Syndrome (MERS) is an acute inflammatory disease of the respiratory system caused by the MERS-CoV coronavirus. The mortality rate for MERS is about 34.5%.

The Mechanism of the Stimforte Effect on the Activation of Target Cell Defense against Viral Infection.

Stimforte in a wide range of concentrations (15-225 µg/mL) totally inhibits the cytopathic activity of hepatitis C virus (HCV) in the Vero-V cell culture. Interferons (IFN) play the most important role in the suppression of infection when the drug is introduced into the culture before the infection. When Stimforte is introduced after the infection, the mechanism of action seems to be different.

Different effects of the immunostimulatory drug Stimforte on infections of hepatitis C virus and herpes simplex virus type 1.

Stimforte, an immune response-stimulating preparation, is active with respect to hepatitis C virus (HCV) and herpes simplex virus type I (HSV-1). The effects of Stimforte in animals infected with either HCV or HSV-1 are fundamentally different. In mice with acute herpes virus infection, Stimforte administration leads to a higher activity of natural killer cells and cytotoxic lymphocytes, and the amount of interferon (IFN) λ grows.